Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, …
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
Older | ||
Bachem Holding AG (BCHMF) (H1 2026) Earnings Call Highlights: Strategic Expansion and Refined ... Despite margin pressure and a conservative outlook adjustment, Bachem Holding AG (BCHMF) secures a major anchor customer and maintains full order books for a robust second half. | ||
 Is Now An Opportune Moment To Examine Bachem Holding AG (VTX:BANB)? Bachem Holding AG ( VTX:BANB ), might not be a large cap stock, but it saw a decent share price growth of 17% on the... | ||
Bachem Holding (VTX:BANB) Ticks All The Boxes When It Comes To Earnings Growth Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks... | ||
Does This Valuation Of Bachem Holding AG (VTX:BANB) Imply Investors Are Overpaying? Key Insights The projected fair value for Bachem Holding is CHF36.15 based on 2 Stage Free Cash Flow to Equity Bachem... | ||
What Is Bachem Holding AG's (VTX:BANB) Share Price Doing? While Bachem Holding AG ( VTX:BANB ) might not have the largest market cap around , it saw significant share price... | ||
Bachem Holding AG's (VTX:BANB) largest shareholder, Top Key Executive Peter Grogg sees holdings value fall by 9.8% following recent drop Key Insights Bachem Holding's significant insider ownership suggests inherent interests in company's expansion Peter... | ||